MAPT and Alzheimer disease: More recent studies found higher levels of hyperphosphorylated tau in the OE of AD subjects than in those suffering from other neurodegenerative diseases, and its expression with a morphological appearance typical of NFTs is localized to ORN cell bodies (Arnold et al., 2010).